Stockscreener 앱 받기
2.57
4.05%
0.10
시간 외 거래:
2.57
전일 마감가:
$2.47
열려 있는:
$2.46
하루 거래량:
2.53M
Relative Volume:
1.11
시가총액:
$514.95M
수익:
$216.56M
순이익/손실:
$-9.57M
주가수익비율:
-51.71
EPS:
-0.0497
순현금흐름:
$-1.22M
1주 성능:
+0.39%
1개월 성능:
+9.83%
6개월 성능:
+17.35%
1년 성능:
+96.18%
1일 변동 폭
$2.41
$2.705
1주일 범위
$2.41
$2.73
52주 변동 폭
$1.15
$3.15
Cerus Corp Stock (CERS) Company Profile
명칭
Cerus Corp
전화
(925) 288-6000
주소
1220 CONCORD AVENUE, CONCORD, CA
Compare CERS vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CERS
Cerus Corp
|
2.57 | 504.93M | 216.56M | -9.57M | -1.22M | -0.0497 |
ABT
Abbott Laboratories
|
88.50 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
301.14 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.14 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.95 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.68 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Cerus Corp Stock (CERS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-04-12 | 개시 | Craig Hallum | Buy |
| 2023-01-20 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-01-17 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2020-10-08 | 재개 | BTIG Research | Buy |
| 2020-06-16 | 재개 | Cantor Fitzgerald | Overweight |
| 2020-02-26 | 개시 | BTIG Research | Buy |
| 2019-11-13 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2019-08-28 | 개시 | Stifel | Buy |
| 2019-08-23 | 재개 | Stephens | Overweight |
| 2018-01-05 | 재개 | Cantor Fitzgerald | Overweight |
| 2017-12-08 | 재개 | BTIG Research | Neutral |
| 2016-07-07 | 재개 | Cantor Fitzgerald | Buy |
| 2015-12-17 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2014-05-02 | 재확인 | MLV & Co | Buy |
| 2013-04-24 | 재확인 | Cantor Fitzgerald | Buy |
| 2013-03-15 | 재확인 | MLV & Co | Buy |
| 2012-04-17 | 개시 | Cantor Fitzgerald | Buy |
| 2012-02-29 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2011-11-10 | 재확인 | MLV & Co | Buy |
| 2011-06-03 | 개시 | Wedbush | Outperform |
| 2011-03-04 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2010-03-09 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2009-08-26 | 업그레이드 | Avondale | Mkt Perform → Mkt Outperform |
모두보기
Cerus Corp 주식(CERS)의 최신 뉴스
5 Best Genomics Stocks to Buy According to Analysts - Insider Monkey
Cerus Corporation (NASDAQ:CERS) Sees Significant Decrease in Short Interest - MarketBeat
Cerus Corp director Eric Bjerkholt sells $53,180 in stock By Investing.com - Investing.com Australia
Director Eric Bjerkholt Sells 20,454 Shares of Cerus Corp (CERS) - GuruFocus
Cerus Corp director Eric Bjerkholt sells $53,180 in stock - Investing.com UK
Cerus Corp (CERS) director sells 20,454 common shares in open-market trade - Stock Titan
[144] CERUS CORP SEC Filing - Stock Titan
CERS Secures $110M Debt Facility for Enhanced Financial Flexibil - GuruFocus
Cerus Refinances Credit Facilities: $65 Million Term Loan and $30 Million Revolver With MidCap - TradingView
Cerus (NASDAQ: CERS) refinances $65M term loan and $30M revolver - Stock Titan
Cerus secures $110 million debt facility with MidCap Financial By Investing.com - Investing.com Canada
Cerus secures $110 million debt facility with MidCap Financial - Investing.com
$110M refinancing expected to save Cerus up to $3.5M a year - Stock Titan
CERS News | CERUS CORP (NASDAQ:CERS) - ChartMill
Cerus (NASDAQ: CERS) holders back equity plan, board and auditors - Stock Titan
Cerus COO Vivek Jayaraman sells $50,001 in company stock By Investing.com - Investing.com Nigeria
Cerus COO Vivek Jayaraman sells $50,001 in company stock - Investing.com
Cerus (NASDAQ: CERS) director granted 60,000 RSUs under 2024 equity plan - Stock Titan
Cerus (CERS) director receives 60,000 RSUs under 2024 equity plan - Stock Titan
Cerus (CERS) director Jami Nachtsheim awarded 60,000 RSUs, lifting holdings to 268,362 shares - Stock Titan
Cerus (NASDAQ: CERS) COO executes 10b5-1 sale of 16,667 shares at $3 - Stock Titan
Cerus (NASDAQ: CERS) director receives 60,000 RSUs equity award - Stock Titan
Cerus (CERS) director Gregory Dean granted 60,000 RSUs in equity award - Stock Titan
60,000 RSU award lifts Cerus (CERS) director holdings to 192,386 - Stock Titan
Restricted-stock sales reported by issuer (NASDAQ: CERS) - Stock Titan
Cerus Company Profile & Introduction - Moomoo
Significant Cerus shareholder to oppose CEO and pay chair at June 2 vote - Stock Titan
What’s Fueling New Momentum Across Penny Stock Markets? - Kalkine Media
Cerus Corporation Q1 2026 Earnings: Narrowing Loss Beats Estimates Amid Operational ProgressDividend Earnings Report - newsline.com
Q1 2026 Cerus Corp Earnings Call Transcript - GuruFocus
Cerus Corporation (CERS) Gets Upgraded to Buy Post Q1 by BTIG - Insider Monkey
Cerus Corporation (CERS) Q1 2026 Earnings: EPS Surprises to the Upside as Loss NarrowsCrowd Breakout Signals - Newser
Cerus Promotes its COO to Top Job - Medical Product Outsourcing
Cerus Corp stock (US1570851014): turnaround hopes after sharp rally in blood safety specialist - AD HOC NEWS
5 Oversold Growth Stocks to Invest In Now - Insider Monkey
Are NYSE Penny Stocks Showing Mixed Financial Strength? - Kalkine Media
Cerus Corp stock (US1570851014): blood safety specialist in focus after Q1 2026 update - AD HOC NEWS
Cerus Corp stock (US1570851014): blood safety specialist back in focus after latest business update - AD HOC NEWS
Cerus Corp stock (US1570851014): Recent 2.21% gain amid mixed signals - AD HOC NEWS
Cerus Is Finding Its Next Gear In Blood Safety - Finimize
Vivek Jayaraman Sells 16,667 Shares of Cerus (NASDAQ:CERS) Stock - MarketBeat
Cerus corp COO Vivek Jayaraman sells $50,001 in common stock By Investing.com - Investing.com Australia
Cerus corp COO Vivek Jayaraman sells $50,001 in common stock - Investing.com
Cerus (CERS) COO sells 16,667 shares in planned 10b5-1 trade - Stock Titan
Cerus Momentum Builds Amid Healthcare Innovation Buzz On Nasdaq Composite - Kalkine Media
Cerus (NASDAQ:CERS) Sees Unusually-High Trading Volume Following Analyst Upgrade - MarketBeat
Cerus (NASDAQ:CERS) Upgraded by Zacks Research to Hold Rating - MarketBeat
Cerus Corporation Q1 2026 SEC Filing: Financial Statements, Risk Factors, and Management Discussion - Minichart
Cerus Corporation Reports First Quarter 2026 Financial Results - HarianBasis.co
Cerus (NASDAQ:CERS) Upgraded by Wall Street Zen to Buy Rating - MarketBeat
Insider sale filings: CERS (NASDAQ: CERS) reports restricted stock dispositions - Stock Titan
Cerus Corp (CERS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.43%
자본화:
|
볼륨(24시간):